[Phospholipid antigens, thrombosis and repeated fetal death].
Julkunen
H
H
HYKS:n naistentautien ja synnytysklinikat, Helsinki.
Jouhikainen
T
T
Kaaja
R
R
D000026:Abortion, Habitual / Q000276:immunology*; D000328:Adult; D000941:Antigens / Q000032:analysis*; D001241:Aspirin / Q000627:therapeutic use; D015415:Biomarkers / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005313:Fetal Death / Q000209:etiology* / Q000517:prevention & control; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000276:immunology*; D011247:Pregnancy; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D020246:Venous Thrombosis / Q000276:immunology* / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000941:Antigens; D015415:Biomarkers; D010743:Phospholipids; D014859:Warfarin; D006493:Heparin; D001241:Aspirin
Fosfolipidivasta-aineet, tromboosi ja keskenmenot.